{"disease":{"id":"behavioral-variant-frontotemporal-dementia","name":"behavioral variant frontotemporal dementia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04363684","title":"ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)","phase":"","overall_status":"RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT06059313","title":"Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT03272230","title":"Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System","phase":"NA","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT06604520","title":"Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03088956","title":"Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)","phase":"","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT04686266","title":"Improving Self-Care of Behavioral Variant Frontotemporal Dementia Caregivers","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT06761729","title":"The Ketogenic Diet in the Treatment of Behavioral Variant Frontotemporal Dementia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT04883229","title":"tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of California, San Francisco","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}